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Available online 25 March 2008Krüppel-like transcription factors (Klfs) modulate fundamental cell processes. Cardiac myocytes are
terminally-differentiated, but hypertrophy in response to stimuli such as endothelin-1. H2O2 or cytokines
promote myocyte apoptosis. Microarray studies of neonatal rat myocytes identiﬁed several Klfs as
endothelin-1-responsive genes. We used quantitative PCR for further analysis of Klf expression in
neonatal rat myocytes. In response to endothelin-1, Klf2 mRNA expression was rapidly increased (∼9-fold;
15–30 min) with later increases in expression of Klf4 and Klf6 (∼5-fold; 30–60 min). All were regulated as
immediate early genes (cycloheximide did not inhibit the increases in expression). Klf5 expression was
increased at 1–2 h (∼13-fold) as a second phase response (cycloheximide inhibited the increase). These
increases were transient and attenuated by U0126. H2O2 increased expression of Klf2, Klf4 and Klf6, but
interleukin-1β or tumor necrosis factor α downregulated Klf2 expression with no effect on Klf4 or Klf6.
Of the Klfs which repress transcription, endothelin-1 rapidly downregulated expression of Klf3, Klf11 and
Klf15. The dynamic regulation of expression of multiple Klf family members in cardiac myocytes suggests
that, as a family, they are actively involved in regulating phenotypic responses (hypertrophy and apoptosis)
to extracellular stimuli.
© 2008 Elsevier B.V. Open access under CC BY-NC-ND license.Keywords:
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C2H2 zinc ﬁnger transcription factors possess two cysteine and
two histidine residues which co-ordinate Zn2+ within each ﬁnger to
form a conserved DNA-binding structure. Sp1-like proteins and
Krüppel-like factors (Klfs) each have three C2H2 zinc ﬁngers at their
C-termini, and Klfs are distinguished by a highly conserved interﬁnger
space sequence [1]. The seventeen mammalian Klfs which have been
identiﬁed are now designated Klf1-17 [2,3], though many have
alternative names. Several were named according to the tissues in
which they were originally shown to be enriched (e.g. Klf1 is erythroid
Eklf, Klf2 is lung Lklf, Klf4 is gut Gklf, Klf5 is intestinal Iklf and Klf15 is
kidney Kklf [2]). Other Klfs are widely expressed including Klf3 (basic
Bklf), Klf6 and Klf7 (ubiquitous Uklf). Klf9 was identiﬁed as a basal
transcription element binding (BTEB) protein, with Klf5 and Klf13 as
homologues (BTEB2 and BTEB3, respectively). Klf10 and Klf11 were
identiﬁed as early genes induced by transforming growth factor β and
were named TIEG and TIEG2, respectively.
Klfs bind to consensus GC-rich or CACCC sequences through the
three C-terminal zinc ﬁngers [1]. The frequency of such sequences in+44 20 7594 3419.
-NC-ND license.gene promoters, coupled with the high sequence identity between
Klf proteins in their DNA-binding domains, raises questions relating
to the speciﬁcity of any Klf for a particular promoter and potential
functional redundancy. Nevertheless, Klfs can be clustered according
to whether they act primarily as transcriptional repressors and/or
activators, and the domain structure of the N-terminal regulatory
regions. Klf3, Klf8 and Klf12 recruit C-terminal binding proteins
(CtBPs) to repress transcription, whereas Klf9, Klf10, Klf11, Klf13 and
Klf16 repress transcription through interaction with mSIN3a [1,4].
Klf15 also represses transcription, though themechanism is not clear.
Klf2, Klf4, Klf5, Klf6, and Klf7 are largely transcriptional activators [1],
but may suppress gene expression in speciﬁc circumstances (e.g. Klf5
negatively regulates expression of Klf4 [5]). In addition to inter-
actions with other proteins, post-translational modiﬁcations (e.g.
phosphorylation or acetylation) regulate the transactivating activ-
ities of different Klfs [1,6]. Globally, Klfs regulate fundamental
cellular responses such as growth, apoptosis, angiogenesis and pro-
liferation. For example, Klf5 overexpression is associated with cell
proliferation, whereas Klf2, Klf4 and Klf6 are more consistently
implicated in cell cycle arrest [7–9]. Klf4 and Klf5 may both promote
apoptosis induced by oxidative stress though the mechanism is
unclear [9].
Mammalian cardiac myocytes (the contractile cells of the heart)
become terminally-differentiated shortly after birth. Subsequent
growth of the heart results from an increase in size of individual
Table 1
Primers used for QPCR validation of microarray data
Gene Accession no. Size (bp) Forward primer Reverse primer
Gapdh NM_017008 83 GCTGGCATTGCTCTCAATGACA (1738–1759) TCCACCACCCTGTTGCTGTA (1801–1820)
Il1rl1 NM_013037 84 GTCTCAAGAGATCGTCTGAAG (418–438) CGATTCAGGGCTTCTGATAAC (481–501)
Irs2 XM_573948 107 CACCTACGCAAGCATCGACT (3921–3940) GATTCAGAGTCTTCGACGAG (4008–4027)
Klf2 NM_001007684 173 ACTTGCAGCTACACCAACTG (805–824) CTGTGACCCGTGTGCTTG (960–977)
Klf3 NM_001105742 165 TCATGTACACCAGCCACCTG (691–710) TAGTCAGTCCTCTGTGGTTC (837–856)
Klf4 NM_053713 175 TCAAGAGCTCATGCCACCGG (1180–1199) CTCGCCTGTGTGAGTTCGCA (1335–1354)
Klf5 NM_053394 212 AGCTCACCTGAGGACTCATA (1437–1456) GTGCGCAGTGCTCAGTTCT (1631–1649)
Klf6 NM_031642 126 CCTTACAGATGCTCTTGGGA (854–873) GGAGAAACACCTGTCACAGT (960–979)
Klf9 NM_057211 124 TGGCTGTGGGAAAGTCTATGG (954–974) CTCGTCCGAGCGCGAGAACT (1058–1077)
Klf10 NM_031135 201 TACTGATGTCTTCACCTACAG (1079–1099) GTACCACAAACATGACCGTG (1260–1279)
Klf11 NM_001037354 165 AACAGAATCACCTTAGCAGAG (1499–1519) AACAGCCCAGAGACCATGG (1645–1663)
Klf15 NM_053536 164 GATGAGTTGTCACGGCACC (1371–1389) CACTGCGCTCAGTTGATGG (1516–1534)
Nucleotide positions in transcripts are shown in parentheses for each primer. mRNA sequences (accession numbers provided) for established genes were obtained from the Rat
Genome Database (http://rgb.mcw.edu, viewed at http://www.ncbi.nlm.nih.gov/entrez).
Table 2
Regulation of Klf isoform expression by ET-1 in cardiac myocytes (microarray analysis)
Gene
symbol
Probeset ID Time (h)
0.5 1 2 4
Signiﬁcantly changed
Klf2(p) 1376569_at, 1386041_a_at, 1394068_x_at 3.50 3.22 0.98 1.20
Klf3 1378332_at, 1389479_at 0.88 0.65 0.60 1.08
Klf4 1387260_at 1.98 3.60 2.69 1.79
Klf5 1368363_at, 1394039_at 1.02 2.68 4.61 1.74
Klf6 1387060_at, 1388986_at, 1395557_at 2.36 4.25 2.05 1.71
Klf9 1370209_at, 1371864_at 1.03 1.22 1.61 1.27
Klf10 1368650_at 0.77 0.85 2.14 1.50
Klf11 1379914_at 0.89 0.63 0.56 0.48
Klf15 1368249_at, 1381396_s_at 0.86 0.53 0.27 0.45
Not signiﬁcantly changed
Klf13 1375177_at, 1383013_at 1.07 1.10 1.58 1.67
Klf16 1374231_at 1.06 1.12 1.47 1.11
Cardiac myocytes were exposed to 100 nM endothelin-1 for the times indicated. RNA
was extracted and gene expression proﬁling was performed using Affymetrix Rat
Genome 230 2.0 arrays. Results are the mean expression relative to controls for n=3
(0.5 or 4 h), 6 (2 h) or 8 (1 h) separate sets of samples. For multiple probesets, the
average of the values is given. (p), predicted gene. Klf1, Klf7 and Klf12 were not
expressedat anysigniﬁcant level in cardiacmyocytes.Klf8 andKlf17werenot identiﬁed
ontheratmicroarrays. Klf14 isnowclassiﬁedasSp6 [1], butwecouldnot identify thison
the ratmicroarrays.
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order to maintain or increase cardiac output. This is associated with
physiological and morphological changes (increases in cell size
and myoﬁbrillogenesis) and changes in gene expression including
increased expression of immediate early genes (IEGs), and re-ex-
pression of genes normally expressed in early development [10].
Stimuli such as endothelin-1 (ET-1), which activate Gq protein-
coupled receptors are particularly implicated in cardiac myocyte
hypertrophy, and promote both the physiological/morphological
changes and the changes in gene expression associated with the
response [11]. In contrast, oxidative stresses or pro-inﬂammatory
cytokines may induce cardiac myocyte apoptosis [12]. Many studies
have examined the intracellular signalling pathways which are ac-
tivated by various stimuli in cardiac myocytes, and these are pre-
sumed to lead to changes in gene and protein expression to promote
hypertrophy or to facilitate myocyte death [13].
Many Klfs are expressed in adult hearts to a degree although the
cell types in which they are expressed cannot be ascertained. For
example, Klf2 is associated with endothelial cells [14,15], and cardiac
endothelial cells could account for expression of Klf2 in whole heart
extracts [16]. As reviewed by Haldar et al. [17], Klf13 and Klf15 are the
only Klfs which have so far been shown to play a role in cardiac
myocytes. Klf13 is highly expressed in adult hearts [18] and is re-
quired for normal cardiac development in Xenopus [19]. Klf15 is
highly expressed in adult hearts and in cardiac myocytes [20,21]. It
appears to be anti-hypertrophic since it is downregulated during
hypertrophy, and overexpression of Klf15 in cardiac myocytes sup-
presses the morphological changes and changes in gene expression
induced by hypertrophic stimuli [21]. Our microarray studies high-
light the dynamic changes in expression of many genes (including
Klfs) induced by H2O2 (an example of oxidative stress) or ET-1 in
cardiac myocytes over 4 h [22–25]. Here, we explore further the
regulation of Klf family members in cardiac myocytes in response to
ET-1, H2O2 and pro-inﬂammatory cytokines [interleukin 1β (IL-1β)
and tumour necrosis factor α (TNFα)]. The dynamic regulation of
expression of multiple Klf family members suggests that, as a family,
they are actively involved in regulating phenotypic responses of cells
to extracellular stimuli.
2. Materials and methods
2.1. Primary culture of neonatal rat cardiac myocytes and preparation of polysomes
Myocytes were dissociated from the ventricles of 2- to 4-day-old Sprague -
Dawley rat hearts by an adaptation of the method of Iwaki et al. [26] as previously
described [27]. Cells were plated at 4×106 cells/60 mm Primaria culture dish (BD
Biosciences) for 18 h in 15% (v/v) foetal calf serum, then serum was withdrawn
for 24 h before experimentation. Myocytes were exposed to ET-1 (100 nM), H2O2
(0.2 mM), IL-1β (100 ng/ml) or TNFα (10 ng/ml) with or without pre-treatment(10 min) with inhibitors (10 μM U0126; 50 μM LY294002; 5 μM SB203580). Cardiac
myocyte polysomes were prepared by sucrose density centrifugation (0.8–1.6 M
sucrose gradients; 5 ml) as previously described [25]. Fractions were collected
by upward displacement (fraction 1 from the top of the gradient, 0.8 M sucrose;
fraction 12 from the bottom of the gradient, 1.6 M sucrose) whilst monitoring
absorbance at 254 nm.
2.2. RNA preparation and quantitative PCR (qPCR)
Total RNA and polysome RNA (fractions 6–11 of the sucrose gradients) were ex-
tracted and cDNA synthesized using reverse transcription as previously described
[22,25]. qPCR was performed using a Real Time PCR System (Model 7500, Applied
Biosystems) as described [25] using primers designed to amplify mRNA sequences
across an intron (Table 1). qPCR analysis of glyceraldehyde 3-phosphate dehydrogenase
(Gapdh) was performed as a control and the relative quantiﬁcation protocol was used.
PCR conditions were 50 °C for 2 min, 95 °C for 10 min (Jump-Start Taq polymerase
activation step), followed by 40 cycles of 95 °C for 15 s and 59 °C for 60 s. Following
qPCR, dissociation curve analysis was routinely performed to check for aberrant
ampliﬁcation products (e.g. primer dimers).
2.3. Western blotting
Cardiac myocyte nuclear extracts were prepared andWestern blotting performed
essentially as described [28]. Extracts from 1.8×106 cells were analysed with sep-
aration of proteins on 10% (v/v) polyacrylamide gels. Nitrocellulose blots were probed
with Klf6 rabbit polyclonal antibodies (Santa Cruz Biotechnology Inc.; Klf6(R-173),
Fig.1. Regulation of Klf expression by ET-1. Cardiacmyocytes were exposed to 100 nM ET-1 for the times indicated. RNAwas extracted and expression ofmRNAs for different Klf family
members (A, Klf2; B, Klf4; C, Klf6; D, Klf5; E, Klf9; F, Klf10; G, Klf3; H, Klf11; I, Klf15) analysed by qPCR. Results are expressed relative to unstimulated controls and aremeans±S.E.M. for
at least 4 independent preparations of myocytes.
Fig. 2. Klf2, Klf4 and Klf6, but not Klf5, are upregulated as immediate early genes by ET-1.
Cardiac myocytes were unstimulated or exposed to 20 μM cycloheximide (CX, open
bars), 100 nM ET-1 (black bars), or ET-1 in the presence of cycloheximide (grey bars) for
0.5 h (Klf2, Klf4, Klf6) or 1 h (Irs2, Klf5, Il1rl1). RNA was extracted and expression of
mRNAs for Klf2, Klf4, Klf6 and Irs2 (A, immediate earlygenes) or Klf5 and Il1rl1 (B, second
phase genes) analysed by qPCR. Results are expressed relative to unstimulated controls
and aremeans±S.E.M. for 3 or 4 independent preparations ofmyocytes. ⁎pb0.01 relative
to ET-1 alone (one-way ANOVA repeated measures with TUKEY post-test).
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metry as described [29].
3. Results
3.1. ET-1 regulates expression of multiple klf family members in cardiac
myocytes
Ourmicroarray studies (with Affymetrix rat genome230 2.0 arrays)
of the effects of ET-1 on cardiac myocyte gene expression over 4 h [25]
identiﬁed Klfs as a family of transcription factors which appeared to be
dynamically regulated at the mRNA level. Mining the data speciﬁcally
for Klfs, we identiﬁed rapid and transient increases in expression of
Klf2, Klf4, Klf5, Klf6, Klf9 and Klf10, with concomitant downregulation
of Klf3, Klf11 and Klf15 (Table 2). There was no statistically signiﬁcant
change in expression of Klf13 or Klf16, although Klf13 exhibited a small
(non-signiﬁcant; one-way ANOVA with Tukey post-test) increase in
expression over 2– 4 h. Klf1 (probeset 1382033_at), Klf7 (probesets
1380363_at,1377618_at,1384497_at) andKlf12 (probeset 1385545_at)
were not consistently called “present” with low ﬂuorescence values
and are thus expressed at minimal levels. We could not identify Klf8,
Klf14 (Sp6) or Klf17 on the arrays.
Using qPCR, we examinedmore carefully the effects of 100 nMET-1
on Klf mRNA expression. Klf2 mRNA expression was signiﬁcantly
increasedwithin 15min, withmaximal expression (∼9-fold relative to
controls) at 30 min (Fig. 1A). Klf4 and Klf6 mRNAs were also up-
regulated (Fig.1, B and C), though the relative stimulationwas less (∼5-
fold relative to controls) and the response was delayed relative to Klf2
(maximal expression at 0.5–1 h). Klf5mRNAwas upregulated from 1 h,
with maximal expression at 1.5 h (∼13-fold relative to controls)
(Fig. 1D). For these Klfs, the increase in expression was transient, with
expression of Klf2 returning to baseline within 90 min and expression
of Klf4, Klf5 and Klf6 declining to basal levels within 4 h. The increasesin expression of Klf9 and Klf10 were relatively small (maximal
expression b 2-fold at 1.5–2 h) although levels remained elevated
over 4–6 h (Fig. 1, E and F). Consistent with our microarray data, Klf3,
Klf11 and Klf15 were downregulated in response to ET-1. Whereas the
decrease in expression of Klf3 was transient with minimal expression
at ∼30 min (Fig. 1G), the decrease in expression of Klf11 and Klf15
was sustained over at least 6 h (Fig.1, H and I). It is notable that the Klfs
which were downregulated and those with only a small increase in
expression are largely associated with transcriptional repression,
whereas the Klfs with the greatest increases in expression (Klf2, Klf4,
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[1,4,6]. Further studies focused on this latter group.
3.2. Regulation of Klf2, Klf4, Klf5 and Klf6 by ET-1
To determine whether Klf2, Klf4, Klf5 and Klf6 mRNAs were up-
regulated as IEGs (i.e. the increase in expression is regulated by pre-
existing transcription factors and does not require synthesis of new
proteins), we examined the effects of 20 μM cycloheximide (to inhibit
protein synthesis). Cycloheximide alone increased the expression of
Klf2, Klf4 and Klf6mRNAs (Fig. 2A; probably due to activation of stress-
activated signalling pathways [30,31]), but did not inhibit the increase
in expression induced by ET-1. However, the increase in expression of
Klf5 by ET-1 was inhibited by cycloheximide (Fig. 2B), indicating that
de novo protein synthesis is required for upregulation of Klf5 mRNA.
Thus, Klf2, Klf4 and Klf6 are regulated as IEGs in response to ET-1,
whereas Klf5 is a second phase gene.
ET-1 potently activates the extracellular signal-regulated kinases
1/2 (ERK1/2) in cardiac myocytes [32]. We used 10 μM U0126 (a
selective inhibitor of the ERK1/2/5 cascades [33–35], though ERK5 is
not signiﬁcantly activated by ET-1 [24]) to determine whether the
increase in expression of Klf2, Klf4, Klf5 and Klf6 requires ERK1/2
signalling. U0126minimally affected basal expression of each Klf, butFig. 3. Upregulation of Klf2, Klf4, Klf6 and Klf5 by ET-1 is mediated in part through the ERK1/
(10 μMU0126, 50 μMLY294002, 5 μM SB203580), to 100 nM ET-1 alone or to ET-1 in the prese
Klf4, Klf6 or Klf5 analysed by qPCR. A, Effects of U0126 on expression of Klf mRNAs at 0.5 (Klf2
at 1 h. Results are expressed relative to unstimulated controls and aremeans±S.E.M. for 4 or 5
way ANOVA repeated measures with TUKEY post-test).partially inhibited the ET-1-induced increase in expression of Klf2
(56±4% inhibition at 30 min; mean±SEM, n=5), Klf4 (43±9% in-
hibition at 1 h; n=4), Klf5 (72±8% inhibition at 1 h; n=4) and Klf6
(45±8% inhibition at 1 h; n=4) (Fig. 3A). These data suggest that
ERK1/2 signalling is required, at least in part, for the upregulation of
Klf2, Klf4, Klf5 and Klf6 mRNAs by ET-1.
Signalling through phosphoinositide 3′ kinase (PI3K) may increase
expression of Klf2 [36], and p38-MAPK is activated by ET-1 in cardiac
myocytes [37], so we examined the effects of 50 μM LY294002 or 5 μM
SB203580 (selective inhibitors of PI3K and p38-MAPK, respectively
[34]). Surprisingly, LY294002 increased basal expression of Klf2 and
Klf4 in cardiac myocytes and promoted further the increase in ex-
pression induced by ET-1 (Fig. 3B), indicating that PI3K signalling is not
required for the upregulation induced by ET-1 and suggesting that
basal PI3K signalling negatively regulates Klf2/Klf4 expression.
LY294002 did not affect Klf6 expression, but attenuated the increase
in expression of Klf5 by ET-1. Since basal PI3K signalling is required for
protein synthesis in cardiac myocytes [38], the effect of LY294002 on
the increase in Klf5 induced by ET-1 (which requires de novo protein
synthesis; Fig. 2B) may be a reﬂection of this. SB203580 had aminimal
effect on the basal expression of Klf2, Klf4, Klf5 or Klf6, or on the
increase in expression induced by ET-1 (Fig. 3B). It is unlikely that p38-
MAPK signalling plays a signiﬁcant role in the response.2 cascade. Cardiac myocytes were unstimulated (Control), or exposed to inhibitors alone
nce of each inhibitor for 0.5 or 1 h. RNAwas extracted and expression of mRNAs for Klf2,
) or 1 h (Klf4, Klf5, Klf6). B, Effects of LY294002 or SB203580 on expression of Klf mRNAs
independent preparations of myocytes. ⁎pb0.05, #pb0.001 relative to ET-1 alone (one-
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Given the increasing evidence for translational regulation of
speciﬁc mRNAs [39,40], we performed translation-state analysis of
Klf2, Klf4, Klf5 or Klf6 mRNAs. We used qPCR to compare the relative
levels of expression in the total RNA pool and in RNAs associated with
cardiac myocyte polysomes (prepared by sucrose density centrifuga-
tion; Fig. 4, A and B). Klf2, Klf4 and Klf6 mRNAs were marginally
enriched in cardiac myocyte polysomes in unstimulated cells and,
following stimulation with ET-1 (1 h), the relative increase in the
polysomes was at least as great as in the total RNA pool (Fig. 4, C–E).
Klf2 was increased 5.6-fold in the polysomes (4.8-fold in total RNA),
Klf4 was increased 6.4-fold (5.0-fold in total RNA) and Klf6 was
increased 4.6-fold (4.8-fold in total RNA). Klf5 mRNA was marginally
decreased in the polysomes relative to the total pool, but the increase
in expression induced by ET-1 in the polysomes (4.3-fold) was slightly
higher than in the total pool (3.9-fold) (Fig. 4F).We therefore expect all
these Klfs to be efﬁciently translated into protein. Consistent with this,
Klf6 protein (detected as bands of ∼38–40 kDa on Western blots) was
increased in cardiac myocytes exposed to ET-1, with maximal ex-
pression at ∼1 h (Fig. 4G). It could be argued that early genes should beFig. 4. Translation-state analysis of Klf mRNAs. Cardiac myocytes were unstimulated (Contro
were prepared from the same myocyte preparations using sucrose density centrifugation. A
each fractionwith ethidium bromide staining to highlight 28 S, 18S and 5S ribosomal RNAs. Fr
Klf6 (E), Klf5 (F), Irs2 (H) or Il1rl1 (I) in total RNA and polysome RNA pools was analysed by qP
means±S.E.M. for 3 or 4 independent preparations of myocytes. ⁎pb0.05, ⁎⁎pb0.001 relati
TUKEY post-test). G, Western blotting of Klf6 protein in cardiac myocytes exposed to ET-
densitometric analysis in the lower panel (results are means±S.E.M. for 3 independent myoefﬁciently translated and this may be a property of all such genes.
However, Irs2 was upregulated as an IEG by ET-1 (no inhibition by
cycloheximide, Fig. 2A), but the mRNA was not enriched in the poly-
somes and the increase in the polysomes was signiﬁcantly less than
that in the total RNApool (Fig. 4H). Similarly, for interleukin 1 receptor-
like 1 (Il1rl1), a second phase gene (upregulation was inhibited by
cycloheximide; Fig. 2B), the increase in expression in the polysomes
was signiﬁcantly less than in the total RNA pool (Fig. 4I). It is therefore
notable that Klf2, Klf4, Klf5 and Klf6 mRNAs are efﬁciently recruited to
the polysomes for translation into protein.
3.4. Regulation of Klf2, Klf4 and Klf6 by H2O2 and pro-inﬂammatory
cytokines
We considered whether other stimuli also regulate expression of
Klf2, Klf4 or Klf6 mRNAs. H2O2 (0.2 mM) promotes cardiac myocyte
apoptosis [41], but also stimulates ERK1/2 (and other pathways) [42],
and stimulated a transient increase in expression of Klf2 (Fig. 5A).
However, the response was less than that of ET-1 (∼3.6-fold) and was
delayed (maximal increase at 1 h) (Fig. 1A). Consistent with our
previous report [23], 0.2 mM H2O2 upregulated Klf4 and Klf6 mRNAsl) or exposed to 100 nM ET-1 (1 h). RNAwas extracted for the total RNA pool. Polysomes
, A254 proﬁles for sucrose density gradients. B, Agarose gel electrophoresis of RNA from
actions 6–11 were pooled for polysomal RNA. Expression of mRNAs for Klf2 (C), Klf4 (D),
CR. Results are expressed relative to levels in total RNA from unstimulated cells and are
ve to Control (total RNA); #pb0.01 relative to ET-1 (total RNA) (one-way ANOVA with
1 for the times indicated. A representative image is shown in the upper panel, with
cyte preparations).
Fig. 5. H2O2 increases expression of Klf2, Klf4 and Klf6 mRNA in cardiac myocytes. A–C, Cardiac myocytes were exposed to 0.2 mM H2O2 for the times indicated. RNA was extracted and
expressionofmRNAs forKlf2 (A), Klf4 (B), or Klf6 (C) analysedbyqPCR. Results are expressed relative to unstimulatedcontrols and aremeans±S.E.M. for at least 4 independent preparations
ofmyocytes. D and E, Cardiacmyocyteswere unstimulated (Control) or exposed to 0.2mMH2O2 (1 h) in the absence or presence of 5 μMSB203580 or 10 μMU0126 (D), or 50 μMLY294002
(E). Expression ofmRNAs for Klf2 (pale grey bars), Klf4 (black bars), or Klf6 (dark grey bars)was analysed by qPCR. Results are expressed relative to levels in unstimulatedmyocytes and are
means±S.E.M. for 5 (D) or 7 (E) independent preparations of myocytes. ⁎pb0.001, #pb0.01 relative to H2O2 alone (one-way ANOVAwith TUKEY post-test).
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over at least 6 h (Fig. 5, B and C). We have observed a similar delay in
induction of other IEGs by H2O2 compared with ET-1 (e.g. Fos family
members, unpublished data), which may reﬂect the delayed time
course for activation of ERK1/2 signalling (maximal activation of
ERK1/2 by ET-1 is at ∼5min [43]; maximal activation by H2O2 is at 15–
30 min [42]). Consistent with a role for ERK1/2 signalling, U0126
inhibited the increase in expression of Klf2, Klf4 and Klf6 by H2O2
(Fig. 5D). As with ET-1, SB203580 did not affect the response to H2O2
(Fig. 5D), whereas LY294002 enhanced the response (Fig. 5E). In
endothelial cells, Klf2 is downregulated by TNFα [15]. IL-1β or TNFα
profoundly and rapidly (from ∼1 h) downregulated Klf2 mRNA ex-
pression, a response which was sustained over at least 6 h (Fig. 6, A
and B). Neither cytokine signiﬁcantly affected the expression of Klf4 orFig. 6. Il-1β or TNFα promote downregulation of Klf2. Cardiac myocytes were exposed to 10
expression of Klf2 mRNA analysed by qPCR. Results are expressed relative to unstimulated
C, Cardiacmyocyteswere unstimulated (Control) or exposed to 100 ng/ml Il-1β (1 h) in the ab
Klf2 mRNA analysed by qPCR. Results are expressed relative to levels in unstimulated myocy
to Il-1β alone (one-way ANOVA with TUKEY post-test).Klf6 (data not shown). The decrease in expression of Klf2 in response
to IL-1β was not affected by either SB203580 or U0126, although
LY294002 (which itself increased expression of Klf2 mRNA, Fig. 3B)
restored the baseline levels of expression (Fig. 6C).
4. Discussion
4.1. Regulation of gene expression by Klf family members
Many studies of individual Klfs relate to speciﬁc cells/tissues in
which they are highly expressed or for which the phenotype of a
transgenic mouse suggests they may play some role. Thus, most
studies of Klf2 focus on its regulation in lung tissue, endothelial cells or
T cells, whereas many studies of Klf4 are in gut, endothelial cells or0 ng/ml Il-1β (A) or 10 ng/ml TNFα (B) for the times indicated. RNA was extracted and
controls and are means±S.E.M. for at least 4 independent preparations of myocytes.
sence or presence of 50 μMLY294002, 5 μMSB203580 or 10 μMU0126 and expression of
tes and are means±S.E.M. for 3 independent preparations of myocytes. ⁎pb0.01 relative
1235T.E. Cullingford et al. / Biochimica et Biophysica Acta 1783 (2008) 1229–1236smooth muscle cells, and Klf5 is studied largely in gut or smooth
muscle cells. Although there are indications that Klfs are transcrip-
tionally regulated in these various cells (e.g. Klf2 expression is in-
creased by shear stress in endothelial cells [14]), and there is an
indication of interplay between Klf family members (e.g. Klf4 and Klf5
appear to operate in an antagonistic manner to regulate cell cycle
progression [8]), few studies consider the regulation and function of
the Klfs as a family. Our data demonstrate substantial and dynamic
regulation of nine Klfs by ET-1 in a single cell type (Fig. 1) with at least
three regulated as IEGs (Fig. 2A), suggesting that Klfs potentially play a
much more signiﬁcant role in the phenotypic responses of more cell
types than has so far been considered.
Klfs are deﬁned by the high degree of homology in their C-terminal
DNA-binding domains [1,6]. It is probably not surprising, therefore,
that all bind to similar consensus DNA sequences or, with 17 family
members, that such elements are relatively common in gene pro-
moters. The Klfs form two principal groups of transcriptional re-
pressors (acting through CtBPs or mSin3a) plus a group which are
primarily transcriptional activators, and it could be argued that the
different Klf groups all do bind to similar sequences but the effect
depends onwhether theKlf is an activator or repressor and, if the latter,
the mode of action. An additional factor could be that different cells
express different Klfs and interactions with other cell-speciﬁc tran-
scription factors may result in differential gene expression. In cardiac
myocytes, we detected expression of at least 11 Klfs (Table 2), with
regulation of several family members from each of the activator/
repressor groups by ET-1 (Fig. 1), suggesting that (at least in this
system) neither tissue speciﬁcity nor classiﬁcation according to global
function is responsible for functional differences between individual
Klfs. Since there is evidence for functional speciﬁcity in other cells
[44,45], minor variations in primary and secondary structure may be
sufﬁcient for individual Klfs to have differing afﬁnities for precise
sequences in various gene promoters. Expression of any individual
gene may therefore reﬂect the balance of Klfs expressed at any
particular time in relation to the precise DNA-binding sites which can
be accessed by them.
4.2. Regulation of expression of Klf2, Klf4, Klf5 and Klf6
Of the Klfs which were upregulated by ET-1, Klf2 mRNA expression
increased very rapidly and transiently (Fig. 1A), and it was regulated as
an IEG (Fig. 2A). Partial inhibition of the response by U0126 (Fig. 3A)
suggests that ERK1/2 signalling is required to some degree. ERK1/2
signalling was also required for upregulation of Klf2 by H2O2 (Fig. 5D).
In contrast to endothelial cells subjected to shear stress [36], the
increase in Klf2 expression by LY294002 and enhanced response to ET-
1 in the presence of LY294002 (Fig. 3B) indicated that PI3K signalling
negatively regulates Klf2 expression in cardiac myocytes. ERK5 phos-
phorylation of the transcription factor MEF2 promotes Klf2 expression
in other cells [46], but ERK5 is not signiﬁcantly activated in cardiac
myocytes by ET-1 [24], ERK1/2 do not efﬁciently activateMEF2 [47] and
inhibition of p38-MAPKs (which also phosphorylate MEF2 [47]) by
SB203580 had no effect on Klf2 expression induced by ET-1 (Fig. 3B),
suggesting that MEF2 is not the principal factor involved in this
context. Of the transcription factors associated with the Klf2 promoter
identiﬁed by Ahmed and Lingrel [48], the most probable candidate for
regulating Klf2 expression by ET-1 in our study is CREB. CREB is rapidly
(within 5–10 min) phosphorylated in cardiac myocytes exposed to ET-
1, a response which is inhibited by U0126 [49].
Like Klf2, the increases in expression of Klf4 and Klf6 (Fig. 1, B and C)
were inhibited by U0126, (Figs. 3A and 5D), and both were regulated as
IEGs (Fig. 2A). Ourdata are consistentwith other systems inwhichKlf4 is
regulated as an IEG by 15-deoxy-Δ12,14 prostaglandin J2 [50] or platelet-
derived growth factor [51], and Klf6 is regulated as an IEG by phorbol
esters or serum [52,53]. However, for either Klf4 or Klf6, the potential
transcription factors or mRNA stabilisation factors which promote theincrease in expression are not known. The increase in expression of Klf5
induced by ET-1 was inhibited by cycloheximide (Fig. 2B), so the prin-
cipal factors promoting its expression must be newly-synthesized
proteins, and the responsewas inhibited by U0126 (Fig. 3A), implicating
ERK1/2 signalling in the response. These data are consistent with other
studies inwhich phorbol esters or ﬁbroblast growth factor increase Klf5
expression in smoothmuscle cells in anERK1/2-dependentmanner [54]
and, in ﬁbroblasts, the increase in expression induced by phorbol esters
is inhibited by cycloheximide [55].
Studies of mRNA expression raise the question of whether or not
changes in mRNA expression equate to changes in protein expression.
In cardiac myocytes treated with ET-1, translation-state analysis in-
dicated that mRNAs for Klf2, Klf4, Klf5 and Klf6 were increased to a
similar or greater extent in the polysomes than in the total RNA pool
(Fig. 4). Since ET-1 also increases the global rate of protein synthesis in
cardiac myocytes [56] (illustrated by the increase in A254 proﬁle of
polysome fractions 6–11 with concomitant decrease of monosome
fractions 2–4; Fig. 4A), overall, we would predict that the rate of
synthesis of each of the Klf proteins should be increased at least in
proportion to the mRNA. Consistent with this, we detected a sig-
niﬁcant, transient increase in expression of Klf6 protein following
stimulation with ET-1 (Fig. 4G). Although cellular stresses such as
oxidative stress can generally inhibit translation, 0.2 mM H2O2 does
not have a signiﬁcant effect on global protein synthesis over 4 h, and
our microarray data indicate that Klf2, Klf4, and Klf6 are increased to a
similar extent in the polysomes as in total RNA (data not shown).
4.3. Regulating Klf-dependent gene expression in cardiac myocytes
Downregulation of Klf15 is associated with the hypertrophic
response of cardiac myocytes and may be required for hypertrophy
to develop [21]. However, our data suggest that the situation regarding
Klf-mediated regulation of gene expression in cardiac myocytes is
more complex. In cardiac myocytes exposed to ET-1, we detected a
rapid decrease in expression ofmRNAs for three established repressors
of gene expression (Klf3, Klf11 and Klf15; Fig. 1, G, H and I), with
simultaneous rapid increases in expression of four Klfs more
commonly associated with transcriptional activation (Klf2, Klf4, Klf5
and Klf6; Fig.1, A–D). In response to ET-1, therefore, there appears to be
an immediate overall switch towards increasing Klf-directed gene
expression. However, the increases in expression of Klf2, Klf4, Klf5 and
Klf6, and decrease in expression of Klf3 were transient, with a delayed
increase in expression of Klf9 and Klf10, suggesting that the balance of
Klf-regulated gene expression continues to change. A similar effectwas
detected with H2O2, with an early increase in expression of Klf2, Klf4,
Klf5 and Klf6 and simultaneous decrease in expression of Klf3, Klf11
and Klf15 (Fig. 5 and [23]). In contrast, Il-1β or TNFα promoted down-
regulation of Klf2 expression (Fig. 6) with little effect on Klf4 or Klf6.
Clearly, the genes which each of the Klfs regulates in cardiac myocytes
remain to be established.
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